BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25732180)

  • 1. Fanconi anemia (FA) and crosslinker sensitivity: Re-appraising the origins of FA definition.
    Pagano G; d'Ischia M; Pallardó FV
    Pediatr Blood Cancer; 2015 Jul; 62(7):1137-43. PubMed ID: 25732180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fanconi anemia: cellular and molecular features].
    Macé G; Briot D; Guervilly JH; Rosselli F
    Pathol Biol (Paris); 2007 Feb; 55(1):19-28. PubMed ID: 16904272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From clinical description, to in vitro and animal studies, and backward to patients: oxidative stress and mitochondrial dysfunction in Fanconi anemia.
    Pagano G; Talamanca AA; Castello G; d'Ischia M; Pallardó FV; Petrović S; Porto B; Tiano L; Zatterale A
    Free Radic Biol Med; 2013 May; 58():118-25. PubMed ID: 23376230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
    Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
    Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype.
    Pagano G; Degan P; d'Ischia M; Kelly FJ; Nobili B; Pallardó FV; Youssoufian H; Zatterale A
    Eur J Haematol; 2005 Aug; 75(2):93-100. PubMed ID: 16000125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular basis of Fanconi's anemia].
    Digweed M
    Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.
    Escarceller M; Buchwald M; Singleton BK; Jeggo PA; Jackson SP; Moustacchi E; Papadopoulo D
    J Mol Biol; 1998 Jun; 279(2):375-85. PubMed ID: 9642044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the Fanconi anemia protein FA-C in repair processes of oxidative DNA damages.
    Lackinger D; Ruppitsch W; Ramirez MH; Hirsch-Kauffmann M; Schweiger M
    FEBS Lett; 1998 Nov; 440(1-2):103-6. PubMed ID: 9862435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis of Fanconi anemia: FA-BRCA network -- review].
    Li YS; Zhu XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):805-9. PubMed ID: 19549413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C. elegans: a model of Fanconi anemia and ICL repair.
    Youds JL; Barber LJ; Boulton SJ
    Mutat Res; 2009 Jul; 668(1-2):103-16. PubMed ID: 19059419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fanconi anemia pathway--the way of DNA interstrand cross-link repair.
    Yao CJ; Du W; Zhang Q; Zhang F; Zeng F; Chen FP
    Pharmazie; 2013 Jan; 68(1):5-11. PubMed ID: 23444773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications.
    Shukla P; Solanki A; Ghosh K; Vundinti BR
    Eur J Haematol; 2013 Nov; 91(5):381-93. PubMed ID: 23859405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay of Fanconi anemia proteins in the DNA damage response.
    Wang X; D'Andrea AD
    DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant.
    Tebbs RS; Hinz JM; Yamada NA; Wilson JB; Salazar EP; Thomas CB; Jones IM; Jones NJ; Thompson LH
    DNA Repair (Amst); 2005 Jan; 4(1):11-22. PubMed ID: 15533833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells.
    Kumaresan KR; Sridharan DM; McMahon LW; Lambert MW
    Biochemistry; 2007 Dec; 46(50):14359-68. PubMed ID: 18020456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetics study of chromosomal instability in Fanconi anemia in Tunisia].
    Chbili C; Bouraoui S; El Ghezal H; Saad A
    Ann Biol Clin (Paris); 2014; 72(4):473-8. PubMed ID: 25119806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks.
    Macé-Aimé G; Couvé S; Khassenov B; Rosselli F; Saparbaev MK
    Environ Mol Mutagen; 2010 Jul; 51(6):508-19. PubMed ID: 20120016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.